* Viemed Healthcare Inc VMD.TO is expected to show a rise
in
quarterly revenue when it reports results
* The Lafayette Louisiana-based company is expected to
report a
38.4% increase in revenue to $49.5 million from $35.76 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Viemed Healthcare
Inc is
for earnings of 9 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Viemed
Healthcare
Inc is $15, above its last closing price of $6.23.
This summary was machine generated October 31 at 00:25 GMT. All
figures in US dollars unless otherwise stated